miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3

Journal of Neuroinflammation

Jena J Steinle¹  Eun-Ah Ye² 

[1] Department of Ophthalmology, Wayne State University, 9314 Scott Hall, Detroit, 48201, MI, USA;Department of Anatomy and Cell Biology, Wayne State University, 9314 Scott Hall, Detroit, 48201, MI, USA

关键词: IGFBP-3;    Insulin signaling;    SOCS3;    TNFα;    REC;    miR-15b/16;   

Others  :  1137538
DOI  :  10.1186/s12974-015-0265-0

 received in 2014-12-17, accepted in 2015-02-10,  发布年份 2015

【 摘 要 】

Background

Mechanisms underlying the pathology of diabetic retinopathy are still not completely understood. Increased understanding of potential cellular pathways responsive to hyperglycemia is essential to develop novel therapeutic strategies for diabetic retinopathy. Emerging evidence shows the impact of microRNA (miR) as a potential novel therapeutic target. The purpose of our study was to test the hypothesis that miR-15b and miR-16 are altered by hyperglycemia in retinal endothelial cells (REC), and that miR-15b/16 play key roles in regulating insulin signaling through a reduction in TNFα- and suppressor of cytokine signaling 3 (SOCS3)-mediated insulin resistance pathways.

Methods

Human REC were maintained in normal (5 mM) glucose or transferred to high-glucose medium (25 mM) for 3 days. REC were transfected with miRNA mimics (hsa-miR-15b-5p and hsa-miR-16-5p) 48 h before cell harvest. A final concentration of 30 nM was used when transfected separately (miR-15b and miR-16) and 15 nM was used in combination (miR-15b + miR-16). A negative control group was treated with an equal concentration of a mimic negative control. The levels of miRNA overexpression were verified using quantitative reverse transcription-polymerase chain reaction and real-time PCR. Western blot analyses were performed to study the levels of phosphorylated Akt (Serine 473), Akt, SOCS3, insulin receptor, phosphorylated insulin receptor (tyrosine 1150/1151), and insulin receptor phosphorylated on Tyr960. In addition, ELISA was used to examine cleaved caspase 3 and TNFα. Analyses were done using unpaired Student t test. Data are presented as mean ± S.E.M.

Results

We demonstrated that the expression of miR-15b and miR-16 was reduced in human REC cultured in hyperglycemia. Overexpression of miR-15b and/or miR-16 reduced TNFα and SOCS3 levels, while increasing insulin-like growth factor binding protein-3 (IGFBP-3) levels and the phosphorylation of insulin receptor (IR)^Tyr1150/1151 in REC cultured in hyperglycemia. These, in turn, led to an increase of Akt phosphorylation and decreased cleavage of caspase 3.

Conclusions

miR-15b and miR-16 play a role in the inhibition of insulin resistance via reduced TNFα and SOCS3 signaling and increased IGFBP-3 levels, resulting in REC protection from hyperglycemia-induced apoptosis. This outcome suggests that both miR-15b and miR-16 are potential therapeutic targets for therapeutics for the diabetic retina.

【 授权许可】

   
2015 Ye and Steinle; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Cunha-Vaz J, Ribeiro L, Lobo C: Phenotypes and biomarkers of diabetic retinopathy. Prog Retin Eye Res 2014, 41:90-111.
• [2]Fong DS, Aiello LP, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 2004, 27:2540-53.
• [3]Bai Y, Bai X, Wang Z, Zhang X, Ruan C, Miao J: MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp Mol Pathol 2011, 91:471-7.
• [4]Engerman RL, Kern TS: Hyperglycemia as a cause of diabetic retinopathy. Metabolism 1986, 35:20-3.
• [5]Nyengaard JR, Ido Y, Kilo C, Williamson JR: Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes 2004, 53:2931-8.
• [6]Klein R, Klein BE, Moss SE, Cruickshanks KJ: Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994, 154:2169-78.
• [7]American DA: Diagnosis and classification of diabetes mellitus. Diabetes Care 2013, 36(Suppl 1):S67-74.
• [8]Bahadori M: New advances in RNAs. Arch Iran Med 2008, 11:435-43.
• [9]Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, et al.: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013, 123:2143-54.
• [10]Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, Nakajo S, et al.: MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS ONE 2013, 8:e71480.
• [11]Li X, Yang W, Lou L, Chen Y, Wu S, Ding G: microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma. Dig Dis Sci 2014, 59:1099-107.
• [12]Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R: Diabetes mellitus, a microRNA-related disease? Transl Res 2011, 157:253-64.
• [13]Kantharidis P, Wang B, Carew RM, Lan HY: Diabetes complications: the microRNA perspective. Diabetes 2011, 60:1832-7.
• [14]Kovacs B, Lumayag S, Cowan C, Xu S: MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2011, 52:4402-9.
• [15]Takahashi P, Xavier DJ, Evangelista AF, Manoel-Caetano FS, Macedo C, Collares CV, et al.: MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Gene 2014, 539:213-23.
• [16]Chan LS, Yue PY, Wong YY, Wong RN: MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem Pharmacol 2013, 86:392-400.
• [17]Wang Y, Fan H, Zhao G, Liu D, Du L, Wang Z, et al.: miR-16 inhibits the proliferation and angiogenesis-regulating potential of mesenchymal stem cells in severe pre-eclampsia. FEBS J 2012, 279:4510-24.
• [18]Zhang Q, Jiang Y, Miller MJ, Peng B, Liu L, Soderland C, et al.: IGFBP-3 and TNF-alpha regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci 2013, 54:5376-84.
• [19]Panjala SR, Steinle JJ: Insulin and beta-adrenergic receptors inhibit retinal endothelial cell apoptosis through independent pathways. Neurochem Res 2011, 36:604-12.
• [20]Zhang Q, Jiang Y, Toutounchian JJ, Soderland C, Yates CR, Steinle JJ: Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions. Mol Vis 2013, 19:796-803.
• [21]Steinle JJ: Retinal endothelial cell apoptosis. Apoptosis 2012, 17:1258-60.
• [22]Jiang Y, Zhang Q, Soderland C, Steinle JJ: TNFalpha and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis. Cell Signal 2012, 24:1086-92.
• [23]Kern TS, Du Y, Miller CM, Hatala DA, Levin LA: Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 2010, 176:2550-8.
• [24]Kowluru RA: Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol 2001, 38:179-85.
• [25]Kowluru RA, Koppolu P: Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res 2002, 36:993-9.
• [26]Jiang Y, Pagadala J, Miller D, Steinle JJ: Reduced insulin receptor signaling in retinal Muller cells cultured in high glucose. Mol Vis 2013, 19:804-11.
• [27]Jiang Y, Zhang Q, Steinle JJ: Intravitreal injection of IGFBP-3 restores normal insulin signaling in diabetic rat retina. PLoS ONE 2014, 9:e93788.
• [28]Lau JC, Kroes RA, Moskal JR, Linsenmeier RA: Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina. Mol Vis 2013, 19:1538-53.
• [29]Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, Sala G, et al.: Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. FASEB J 2004, 18:1456-8.
• [30]Lofqvist C, Chen J, Connor KM, Smith AC, Aderman CM, Liu N, et al.: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A 2007, 104:10589-94.
• [31]Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, Liu L, et al.: Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels. Invest Ophthalmol Vis Sci 2012, 53:3004-13.
• [32]Caporali A, Emanueli C: MicroRNA regulation in angiogenesis. Vascul Pharmacol 2011, 55:79-86.
• [33]Fish JE, Srivastava D: MicroRNAs: opening a new vein in angiogenesis research. Sci Signal 2009, 2(52):pe1.
• [34]Guan HJ: How to develop molecular epidemiology in conventional epidemiology survey on eye diseases in China. Zhonghua Yan Ke Za Zhi 2012, 48:196-8.
• [35]Kowluru RA, Kowluru A, Kanwar M: Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Mol Cell Biochem 2007, 296:69-76.
• [36]Du Y, Smith MA, Miller CM, Kern TS: Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 2002, 80:771-9.
• [37]Du Y, Miller CM, Kern TS: Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003, 35:1491-9.
• [38]Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT: The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 2010, 402:491-509.
• [39]Shen XH, Han YJ, Yang BC, Cui XS, Kim NH: Hyperglycemia reduces mitochondrial content and glucose transporter expression in mouse embryos developing in vitro. J Reprod Dev 2009, 55:534-41.
• [40]McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S: MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011, 60:1314-23.
• [41]Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, et al.: miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 2011, 60:2975-84.
• [42]Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
• [43]Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, et al.: A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-17.
• [44]Chakraborty C, Doss CG, Bandyopadhyay S, Agoramoorthy G: Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes. Wiley Interdiscip Rev RNA 2014, 5:697-712.
• [45]Arvey A, Larsson E, Sander C, Leslie CS, Marks DS: Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Biol 2010, 6:363.
• [46]Han J, Jogie-Brahim S, Harada A, Oh Y: Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-kappaB signaling. Cancer Lett 2011, 307:200-10.
• [47]Kim JH, Choi DS, Lee OH, Oh SH, Lippman SM, Lee HY: Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events. Blood 2011, 118:2622-31.